,0,1
0,sealing technologiesinc,9.0
1,institutional buyers,9.0
2,clinical studies,9.0
3,scanner platform,9.0
4,allocation rates,9.0
5,wall street journal,9.0
6,gantry architecture,9.0
7,executive officer,9.0
8,exchange rates,8.764705882352942
9,group purchasing organizations,8.666666666666666
10,tax positions,8.547619047619047
11,local currency,8.543010752688172
12,adverse decisions,8.5
13,dose distributions,8.5
14,marrow irradiation,8.456140350877194
15,longer potentially outstanding,8.428571428571429
16,coverage ratio,8.4
17,legal proceedings,8.336798336798337
18,judicial district,8.333333333333334
19,currency impacts,8.277777777777779
20,quarters,8.267605633802816
21,december31,8.235049430068607
22,alleging misappropriation,8.23076923076923
23,months,8.218798397863818
24,borrowing rate,8.194690265486726
25,maximum capex,8.151515151515152
26,closing submissions,8.126436781609195
27,departmental spending,8.121951219512194
28,exchange rates,8.113543091655266
29,currency impacts,8.111111111111112
30,operating officer,8.08695652173913
31,debt recoveries,8.083333333333334
32,treasury stock method,8.081196581196581
33,september30,8.080689745952348
34,feasible manner,8.077922077922079
35,radiation therapy,8.062687312687313
36,stage cancers,8.055555555555555
37,income tax consequences,8.04095238095238
38,undue reliance,8.0
39,tumors,8.0
40,payment history,7.982905982905983
41,accounting policies,7.962820512820513
42,trade secrets,7.868421052631579
43,generation tomotherapy,7.857142857142858
44,net income,7.770845295055821
45,net income,7.770845295055821
46,harbor provisions,7.769230769230769
47,unrealized gains,7.766612334634775
48,medical practice,7.7627450980392165
49,deliver highly accurate,7.75
50,efficient daily low,7.75
51,conversion features,7.734375
52,cowealth,7.724137931034482
53,component,7.696428571428571
54,minnesota state court,7.6923076923076925
55,international court,7.6923076923076925
56,legal proceedings,7.685635546100662
57,income tax benefit,7.677316017316016
58,credit risk,7.677031509121061
59,credit risk,7.677031509121061
60,software license indemnity,7.666666666666666
61,total leverage,7.6632110579479
62,stock price,7.662737799834574
63,capital expenditure requirements,7.634056054997355
64,treatment solutions,7.617021276595745
65,scheduling order,7.594104308390023
66,financial instruments,7.584398976982097
67,purchase pp&amp,7.578947368421053
68,gains,7.570131396218352
69,radiation therapy,7.562687312687313
70,maintenance services,7.555555555555555
71,unrealized gains,7.541894659212874
72,total debt,7.5394736842105265
73,exchange instruments,7.525575447570333
74,gross profits,7.515015015015015
75,share count,7.5
76,faith belief,7.5
77,exchange expense,7.497715591090805
78,securities laws,7.470094086021505
79,operating decisions,7.461956521739131
80,cost submissions,7.458333333333334
81,debt instrument,7.453703703703704
82,investment category,7.43859649122807
83,final payment,7.438190535751511
84,minimum ebitda,7.432467532467532
85,libor rate floor,7.425459496255956
86,principal amount,7.417953667953668
87,risk factors,7.416666666666666
88,exchange agreements,7.41485949218397
89,exchange adjustments,7.407563025210084
90,average number,7.407407407407407
91,significant judgment,7.402882205513785
92,exchange losses,7.402205882352941
93,accounting policies,7.401417004048583
94,performance stock units,7.3804797353184455
95,oncology systems group,7.379612257661037
96,stock units,7.378582202111614
97,cyberknife,7.377625570776256
98,software license agreements,7.376344086021504
99,capital projects,7.359094457455113
100,market data,7.358649789029537
101,development projects,7.35064935064935
102,unrealized losses,7.338894943330428
103,sales agreements,7.338709677419354
104,fewer systems,7.3375609756097555
105,quarterly installments,7.335664335664335
106,leverage defines,7.335642135642136
107,conversion price,7.331149193548386
108,retrospective approach,7.323529411764706
109,revenue deliverables,7.317361392148928
110,legal fees,7.314694004349176
111,financial institutions,7.291478129713424
112,accounting standards codification,7.282051282051282
113,accounting estimate,7.282051282051282
114,funds rate,7.2780235988200594
115,income tax expense,7.273962089690245
116,unobservable inputs,7.269230769230769
117,major markets,7.261904761904762
118,medical holdingco,7.2535496957403645
119,original maturities,7.244870305845916
120,supporting evidence,7.232142857142858
121,product lines,7.222222222222222
122,install base,7.220588235294118
123,balance sheet arrangements,7.211309523809524
124,inventory purchasing activities,7.209740769835035
125,edge technologies,7.199999999999999
126,employee stock plans,7.1923076923076925
127,secret claim,7.186602870813397
128,income tax expenses,7.186583448913545
129,legal fees,7.1813606710158435
130,capital requirements,7.176913197854498
131,consulting expenses,7.166464401294499
132,principal amount,7.164584395716472
133,radiation therapy systems,7.160248288297069
134,comprehensive loss,7.158730158730158
135,loss account,7.158730158730158
136,financial statements,7.15854624678154
137,net loss,7.1505278347383605
138,product development,7.150252525252526
139,lease agreement,7.149707602339181
140,loan matures,7.1430641821946175
141,losses,7.142414004914005
142,service contract signing,7.138793928620265
143,service contract deferrals,7.138793928620265
144,conversion rate,7.138742684841564
145,bonus expenses,7.128964401294498
146,warranty period services,7.125555555555556
147,deemed past due,7.121951219512195
148,side effects,7.1066666666666665
149,robotic systems,7.097560975609756
150,tradeshow,7.096969696969697
151,customer buyouts,7.089712918660287
152,benefit costs,7.08814935064935
153,misappropriation,7.087912087912088
154,tangible assets,7.084102564102564
155,payment terms,7.076923076923077
156,contracted maturities,7.073170731707317
157,total accounts,7.067959759906741
158,consolidated statements,7.065786065786066
159,sale price,7.06255316364588
160,intangible assets,7.061666666666667
161,intangible assets,7.061666666666667
162,loss position,7.059395801331285
163,market stock units,7.050957481337228
164,foreign currencies,7.050420168067227
165,channel sale,7.049019607843137
166,gross orders,7.046552549122509
167,radixact system,7.041666666666666
168,process,7.038548752834467
169,low risk,7.027777777777778
170,insurance expenses,7.016219303255283
171,interim period,7.012857142857143
172,doubtful accounts,7.011819409029548
173,quoted price,7.006144393241167
174,conversion price,6.9985209545214175
175,deferred rent,6.969777306468717
176,cash flows,6.968375513735669
177,metrics backlog,6.963888888888889
178,america region,6.957264957264957
179,foreign locations,6.955284552845529
180,consulting fees,6.9512931034482754
181,stock price,6.94845208554886
182,convertible notes,6.943836573157956
183,operating leases,6.926956521739131
184,award amount,6.906606606606607
185,related guarantees,6.901408450704225
186,interest method,6.896464646464646
187,principal amount,6.8941441441441444
188,tax expenses,6.893250115580212
189,rotary systems,6.889227642276422
190,share price,6.887096774193548
191,market participant assumptions,6.88245931283906
192,cash flow equivalents,6.881371509367267
193,moderate risk,6.875268125268125
194,doubtful accounts,6.873679837134903
195,capital management,6.873246971607627
196,tax accruals,6.869570267131243
197,net orders,6.864605051385538
198,business plan,6.8613372093023255
199,lower margins,6.855284552845529
200,award amount,6.851051051051051
201,service costs,6.845674920453619
202,hedging activities,6.825065847234416
203,product revenue,6.821726471514007
204,equity investments,6.821339330334832
205,equity conversion component,6.810113916256158
206,conversion rate,6.806114445814595
207,actual performance,6.799283154121865
208,consulting expenses,6.783131067961165
209,actual conditions,6.7814009661835755
210,performance obligation,6.771505376344086
211,currency fluctuations,6.768115942028986
212,common shares,6.759153982517269
213,credit quality,6.749253731343284
214,guidance,6.734741784037558
215,recurring adjustments,6.726190476190476
216,warranty services,6.722222222222222
217,channel sales,6.712365591397849
218,service costs,6.708420018492834
219,net revenue,6.708156561891466
220,parts revenue,6.705273480061016
221,principal amount,6.682762030323006
222,gross orders,6.675964313828391
223,stock options,6.632783882783883
224,pcs,6.601190476190476
225,management,6.600732600732601
226,interest expense,6.599676375404531
227,credit losses,6.580871378402107
228,service revenues,6.55663430420712
229,income taxes,6.55596097118221
230,rotary systems,6.555894308943088
231,service cost component,6.544729542302358
232,fasb issued asu,6.543186582809225
233,term,6.539654460575941
234,financial performance,6.535510978584982
235,maturity date,6.529205607476635
236,marketing expenses,6.523229994855866
237,solely shares,6.521929824561403
238,credit losses,6.521495515380842
239,offering costs,6.505575117370892
240,related expenses,6.502324071510919
241,financial statements,6.499455337690632
242,cowealth,6.4955665024630544
243,conversion components,6.495244565217392
244,company,6.487601154701624
245,early adoption,6.483941733941734
246,service costs,6.475086685159501
247,service revenues,6.473300970873787
248,related costs,6.469860831656606
249,year,6.4584557438794725
250,revenue,6.458375217033721
251,deferred systems,6.445387062566278
252,business finance,6.44179292929293
253,dilutive shares,6.43859649122807
254,dilutive shares,6.43859649122807
255,factors,6.436058700209644
256,taxes,6.432177681473457
257,revenue conversion process,6.431101471514007
258,service revenues,6.423300970873786
259,product orders,6.423186536050614
260,purchase price,6.422184493491795
261,depreciation expense,6.415119913828054
262,net cash,6.4053533042091395
263,infringes,6.4
264,management judgment,6.396471949103528
265,cyberknife,6.377625570776256
266,lease obligations,6.376143790849673
267,licenses,6.375
268,equity conversion components,6.374554910044978
269,cancer care group,6.371428571428572
270,based metrics,6.34909978638999
271,radiation oncology company,6.344567197508374
272,compensation expense,6.34393788325937
273,current period,6.340405836753306
274,stereotactic body,6.333333333333333
275,common stock,6.327290953905014
276,prior year,6.324602946869805
277,revenue,6.314076441805154
278,revenue,6.314076441805154
279,net revenue,6.307571766569828
280,maturity date,6.306983385254413
281,effective date,6.300670253941282
282,service contracts,6.296028243601058
283,conversion shares,6.292019110275689
284,fixed charges,6.290848861283644
285,revenue,6.287004249291785
286,estimable losses,6.281332693128467
287,year period,6.27265172735761
288,loan interest,6.272068511198946
289,accrual reduction,6.2626482213438734
290,receivable balances,6.25887823255896
291,radiosurgery treatments,6.242857142857143
292,product orders,6.241239038313642
293,payment transactions,6.238244473843071
294,systems,6.237133168123125
295,asset restrictions,6.206130268199233
296,product costs,6.199007936507937
297,principal amount,6.197174447174447
298,fiscal year,6.190857411322528
299,office,6.179572192513369
300,financial assets,6.17686274509804
301,pricing methods,6.166666666666667
302,slight offset,6.165044814340589
303,early payment,6.163828107376494
304,debt issuance costs,6.16194831591173
305,management,6.160256410256411
306,fiscal quarter,6.158749466495945
307,measurement period,6.153333333333332
308,revenue recognition process,6.141170915958451
309,system revenue,6.138122135470646
310,cash flows,6.111232656592812
311,combination settlement feature,6.110833333333334
312,installation revenue,6.097266397629381
313,quoted prices,6.091964285714285
314,pcs revenue,6.087949627443045
315,fiscal period,6.079116373822256
316,impact backlog,6.0727598566308245
317,cyberknife system orders,6.069130425145188
318,primarily market,6.054442669288436
319,contract customer support,6.0470719051149
320,training revenue,6.045092484585902
321,classifies accounts,6.022954690055159
322,cash resources,6.022578184591914
323,larger tumors,6.02054794520548
324,secured loan,6.0140319241301015
325,additional equity,6.00946585530764
326,sells advanced radiosurgery,6.0
327,amortization expense,5.992751492775422
328,financial assets,5.989362745098039
329,securities measurement period,5.973273809523809
330,expenses,5.972019956850054
331,significant benefits,5.96584008097166
332,sales transactions,5.935553277594473
333,cyberknife systems,5.9274387986382635
334,net age,5.926814287303884
335,costs,5.923214285714286
336,cash amount,5.888249118683901
337,counterclaims,5.872222222222222
338,marketing expenses,5.871821544151642
339,notes,5.868279150717042
340,system revenue,5.8639970029149735
341,debt securities,5.857834507042254
342,future operations,5.856110154905336
343,installation service revenue,5.849979133209049
344,bonus payments,5.836765615337044
345,probable losses,5.827976190476191
346,tomotherapy systems,5.825671574688097
347,credit losses,5.818003731343284
348,related notes,5.81449385015326
349,parts utilization,5.814102564102564
350,system sales agreement,5.77596208262592
351,fiscal quarter,5.757586675798271
352,order backlog,5.754052628803459
353,commission expense,5.733009708737864
354,sale debt securities,5.726102941176471
355,revenue recognition criteria,5.7189486937362295
356,states dollar,5.709677419354838
357,type lease portion,5.688122605363985
358,share settlements,5.677511961722487
359,company,5.672459893048129
360,common share,5.630081300813008
361,market activity,5.625316455696202
362,revenue contracts,5.6222315220190575
363,share settlement,5.617511961722488
364,cash collections,5.603864734299517
365,system sales,5.592267552182164
366,annual periods,5.563725490196079
367,cyberknife systems,5.56024401765038
368,metrics,5.547905525846702
369,cash flows,5.499625513735669
370,radiosurgery treatments,5.492857142857143
371,lease obligations,5.405555555555555
372,cost basis,5.39636431784108
373,level2 inputs,5.370319945541184
374,fair values,5.359150326797385
375,3million fee,5.35617035546613
376,legal proceedings,5.336798336798337
377,astro tradeshow,5.333333333333333
378,inventories inventories,5.307692307692308
379,unrealized gains,5.307152875175316
380,business,5.301388888888889
381,foreign exchange,5.264705882352941
382,quarter presentation,5.254772822984418
383,contracts range,5.232940562308897
384,note holders,5.207725254480469
385,fewer units,5.1899999999999995
386,term success,5.182072339681985
387,sales contract,5.115953787239566
388,gains,5.110671936758893
389,training revenue,5.074504249291785
390,longer infringes,5.071428571428571
391,radiation therapy,5.062687312687313
392,customer purchase order,5.053168635875403
393,outstanding amount,5.019305019305019
394,cash,5.012740972967027
395,radiation oncology,5.0049950049950045
396,legal fees,4.981360671015843
397,premium shares,4.974561403508772
398,significant risk,4.966374269005848
399,balance sheet,4.961309523809524
400,moderate risk,4.956349206349206
401,separate accounting,4.929487179487179
402,unrealized losses,4.879435483870967
403,payment activity,4.871794871794872
404,trade secrets,4.868421052631579
405,timely manner,4.863636363636363
406,consulting fees,4.851293103448276
407,total leverage,4.845029239766082
408,functional currency,4.833333333333334
409,foreign locations,4.833333333333334
410,support current,4.822521419828641
411,twelve months,4.813084112149532
412,transition method,4.805555555555555
413,edge technologies,4.8
414,tax expense,4.780628756356911
415,comprehensive income,4.779047619047619
416,net income,4.770845295055821
417,insurance,4.768421052631579
418,financial position,4.767973856209151
419,court,4.763736263736265
420,final award,4.7444444444444445
421,bonus,4.74090909090909
422,income taxes,4.724102564102564
423,legal costs,4.719353281853282
424,commercially launched,4.714285714285714
425,applicable margin,4.709677419354838
426,financial institutions,4.708144796380091
427,consolidated basis,4.702194357366771
428,minnesota court,4.6923076923076925
429,financial performance,4.6783681214421255
430,original maturities,4.673441734417344
431,legal accrual,4.658476658476658
432,previously anticipated,4.642857142857142
433,doubtful accounts,4.638938053097345
434,gross amount,4.621621621621622
435,conversion price,4.621471774193548
436,adjustments,4.61344537815126
437,accounts,4.611819409029549
438,contractual agreements,4.607636603028308
439,balance sheets,4.604166666666666
440,aggregate materially,4.60377358490566
441,financial instruments,4.584398976982097
442,major banks,4.583333333333334
443,previously aged,4.576923076923077
444,gross orders,4.575964313828392
445,equity component,4.575738916256158
446,capital resources,4.574633304572908
447,conversion feature,4.567708333333334
448,minimum amount,4.562162162162162
449,principal amount,4.5608108108108105
450,principal amount,4.5608108108108105
451,stock compensation,4.5547107930828865
452,tax audits,4.5476190476190474
453,prepaid taxes,4.530769230769231
454,medical specialty,4.529411764705882
455,high risk,4.527777777777778
456,district court,4.5256410256410255
457,secured leverage,4.517460317460317
458,01changes,4.512820512820513
459,hedging instruments,4.510869565217391
460,common equity,4.509391645640594
461,software,4.5
462,pricing models,4.5
463,international chamber,4.5
464,embedded derivatives,4.5
465,supports precise,4.5
466,good candidates,4.5
467,guided intensity,4.5
468,unique features,4.5
469,dose,4.5
470,neck cancers,4.5
471,maximum amount,4.495495495495495
472,comparable prices,4.489583333333334
473,fewer projects,4.487619047619047
474,higher stock,4.475641025641026
475,center support,4.473684210526316
476,future events,4.465934065934066
477,additional equity,4.4577417173766065
478,term risk,4.45561282932417
479,development expenses,4.448661370991468
480,expenses,4.445631067961164
481,prices,4.441964285714286
482,net amount,4.43967412388465
483,lived intangible,4.439102564102564
484,significant inter,4.43859649122807
485,compensation costs,4.4308554817275745
486,total revenue,4.430644600168978
487,conversion rate,4.4290652654867255
488,libor rate,4.425459496255956
489,current period,4.418837209302326
490,channel mix,4.416666666666666
491,existing orders,4.416504854368932
492,development activities,4.407507914970601
493,common stock,4.4057223264540335
494,interest expense,4.39967637540453
495,principal place,4.398648648648649
496,operating capital,4.398431931575196
497,aggregate basis,4.396877033181522
498,reference rate,4.394690265486726
499,net orders,4.39401681609142
500,radiation beam,4.3896103896103895
501,rotary systems,4.389227642276422
502,exit price,4.387096774193548
503,trading price,4.387096774193548
504,fees,4.380459770114943
505,equity section,4.379310344827586
506,cyberknife,4.377625570776256
507,initial purchaser,4.3770491803278695
508,basis,4.376436781609195
509,collaboration agreements,4.376344086021505
510,individual negotiations,4.375
511,similar expressions,4.37037037037037
512,similar techniques,4.37037037037037
513,thereon,4.368421052631579
514,trade shows,4.368421052631579
515,current year,4.366614987080103
516,interest rate,4.361356932153392
517,hedging activities,4.354477611940299
518,net consisted,4.3544350386455655
519,development projects,4.35064935064935
520,service,4.345252190385981
521,related activities,4.339219395977857
522,sales agreements,4.338709677419355
523,fourth quarter,4.334507042253521
524,lower commissions,4.333333333333334
525,orders,4.330790568654646
526,financial condition,4.3235294117647065
527,united states,4.32258064516129
528,regulatory requirements,4.32258064516129
529,gross profit,4.316602316602317
530,travel expenses,4.3122977346278315
531,working capital,4.311475409836065
532,capital expenditures,4.311475409836065
533,professional services,4.305555555555555
534,late october2015,4.305555555555555
535,prepaid commissions,4.3
536,variable rate,4.294690265486725
537,service period,4.293300970873786
538,related services,4.290297339593113
539,marketing expenses,4.288488210818308
540,credit losses,4.286753731343284
541,foreign currencies,4.285714285714286
542,underlying exposures,4.285714285714286
543,costs,4.270833333333334
544,combination,4.270833333333334
545,early adoption,4.269656019656019
546,level3 inputs,4.269230769230769
547,primarily related,4.2638679976297915
548,related primarily,4.2638679976297915
549,financing receivable,4.256939326946696
550,prior period,4.254873949579832
551,cowealth,4.2535496957403645
552,net revenue,4.252016211014273
553,financial statements,4.249455337690632
554,transaction price,4.244239631336406
555,additional amount,4.2405935347111825
556,accounts payable,4.238938053097345
557,related disclosures,4.234741784037558
558,conversion obligation,4.234375
559,marketing efforts,4.233766233766234
560,taxes,4.230769230769231
561,exchange commission,4.227668845315904
562,similar assets,4.223703703703704
563,step process,4.222222222222222
564,process improvements,4.222222222222222
565,lengthy process,4.222222222222222
566,decreased due,4.221951219512196
567,irrevocably elect,4.214285714285714
568,adjusted ebitda,4.214285714285714
569,services,4.20734126984127
570,prior year,4.20265172735761
571,current assets,4.202170542635659
572,corporate transactions,4.20125786163522
573,commenced construction,4.2
574,service revenue,4.197805220165571
575,prime rate,4.1946902654867255
576,court,4.1923076923076925
577,rotary settlements,4.191666666666666
578,operating activities,4.191434133679429
579,120 days,4.184873949579831
580,quarterly reports,4.181818181818182
581,related receivables,4.177598926894701
582,financial assets,4.176862745098039
583,sales tax,4.1766513056835635
584,type leases,4.173333333333334
585,additional accrual,4.169340463458111
586,license,4.166666666666666
587,unpaid interest,4.166666666666666
588,interest,4.166666666666666
589,additional funds,4.161764705882353
590,comprehensive loss,4.158730158730158
591,system orders,4.158171521035598
592,consecutive trading,4.153846153846153
593,consecutive 30trading,4.153846153846153
594,underlying transactions,4.153638814016173
595,capital leases,4.151475409836066
596,primarily due,4.151077433104428
597,net loss,4.1505278347383605
598,credit,4.149253731343284
599,credit enhancements,4.149253731343284
600,sufficient credit,4.149253731343284
601,administrative expenses,4.145631067961165
602,expenses,4.145631067961165
603,secured loan,4.1430641821946175
604,anticipated drivers,4.142857142857142
605,marketing departments,4.142857142857142
606,marketing initiatives,4.142857142857142
607,13requires measurement,4.142857142857142
608,marketing programs,4.142857142857142
609,service plans,4.139967637540453
610,impairment charges,4.133928571428571
611,cancer tumors,4.133333333333333
612,cancer types,4.133333333333333
613,operating lease,4.131400966183575
614,increased installation,4.122762148337596
615,repayment requirements,4.122580645161291
616,100million offering,4.119047619047619
617,cash,4.112361466325661
618,fixed costs,4.111785714285714
619,geographic region,4.111111111111111
620,based compensation,4.110928174521506
621,current cash,4.108257499157398
622,primarily consisted,4.10604929051531
623,obsolete inventory,4.105263157894736
624,inventory transfers,4.105263157894736
625,economic activities,4.104477611940299
626,activities,4.104477611940299
627,manufacturing activities,4.104477611940299
628,observable inputs,4.102564102564102
629,decreased salaries,4.1
630,radiosurgery systems,4.097560975609756
631,radixact systems,4.097560975609756
632,reporting unit,4.090909090909091
633,facilities costs,4.089285714285714
634,significant items,4.088596491228071
635,differ materially,4.086956521739131
636,lived assets,4.084102564102564
637,valuation allowance assessment,4.083612040133779
638,foreign subsidiaries,4.083333333333333
639,related product,4.081964006259781
640,additional disclosures,4.078431372549019
641,additional installations,4.078431372549019
642,period,4.07
643,equity awards,4.066810344827586
644,interim periods,4.066666666666666
645,intangible assets,4.0616666666666665
646,day period,4.054615384615385
647,lease inception,4.044444444444444
648,lease extension,4.044444444444444
649,radixact system,4.041666666666666
650,smart system,4.041666666666666
651,greater awareness,4.037037037037037
652,net cash,4.036932251577561
653,services revenue,4.03005980484734
654,primarily impacted,4.029126213592233
655,lower headcount,4.0256410256410255
656,advantageous market,4.025316455696203
657,market participants,4.025316455696203
658,active market,4.025316455696203
659,market developments,4.025316455696203
660,cash resources,4.022578184591914
661,counterclaims,4.02054794520548
662,previous year,4.017777777777778
663,system revenue,4.016170915958451
664,current gaap,4.015503875968992
665,accounting purposes,4.012820512820513
666,m6 series,4.012121212121212
667,term debt,4.011168384879725
668,americas region,4.011111111111111
669,debt issuance,4.010162601626016
670,accrued severance,4.009803921568627
671,cyberknife systems,4.008519879719345
672,court,4.0048076923076925
673,rulesand regulations,4.0
674,necessarily indicative,4.0
675,core principle,4.0
676,recognize revenues,4.0
677,practical expedients,4.0
678,reserves,4.0
679,regulatory qualifications,4.0
680,multiple elements,4.0
681,respective elements,4.0
682,bug fixes,4.0
683,exercise,4.0
684,optional physical,4.0
685,shipping addresses,4.0
686,geographic areas,4.0
687,money,4.0
688,determinable dates,4.0
689,specific identification,4.0
690,tables,4.0
691,rely exclusively,4.0
692,temporary impairments,4.0
693,inherently unpredictable,4.0
694,county,4.0
695,named defendant,4.0
696,appeals,4.0
697,discovery,4.0
698,injunctive relief,4.0
699,hong kong,4.0
700,clerical error,4.0
701,subsequently issue,4.0
702,regulatory clearances,4.0
703,actions,4.0
704,payable semi,4.0
705,trading days,4.0
706,trading days,4.0
707,holder,4.0
708,perspective,4.0
709,competitive positioning,4.0
710,advanced capabilities,4.0
711,grown significantly,4.0
712,considerably wider,4.0
713,diffuse wide,4.0
714,focal area,4.0
715,systemic diseases,4.0
716,cells,4.0
717,leaf collimator,4.0
718,multiple sites,4.0
719,iris collimator,4.0
720,designed specifically,4.0
721,continued evolution,4.0
722,regulatory approvals,4.0
723,fully integrated,4.0
724,angles,4.0
725,enable physicians,4.0
726,healthy tissue,4.0
727,times,4.0
728,varies significantly,4.0
729,properly executed,4.0
730,work closely,4.0
731,administrative involvement,4.0
732,japanese yen,4.0
733,swiss franc,4.0
734,indefinitely reinvested,4.0
735,bunker constructions,4.0
736,higher volume,4.0
737,competing technological,4.0
738,rights,4.0
739,historical experience,4.0
740,homogenous nature,4.0
741,priority liens,4.0
742,incise mlcs,4.0
743,specifically designed,4.0
744,expirations,4.0
745,wisconsin facility,4.0
746,radiosurgery conducted,4.0
747,automated workflows,4.0
748,commercial launch,4.0
749,swiss authorities,4.0
750,januaryand augustof,4.0
751,manufacturing space,4.0
752,detail schedule,4.0
753,administrative agent,4.0
754,radixact testing,4.0
755,legal matters,3.9961389961389964
756,service contracts,3.9960282436010592
757,effective period,3.994242424242424
758,cash,3.994162073892631
759,financing activities,3.9885355829547913
760,trading day,3.9846153846153847
761,stockholders equity,3.9793103448275864
762,quarterly basis,3.9749216300940438
763,revenue,3.974504249291785
764,recognize revenue,3.974504249291785
765,revenue deals,3.974504249291785
766,revenue prospects,3.974504249291785
767,deferred cost,3.9728260869565215
768,net change,3.9713895127428964
769,cash flows,3.9683755137356695
770,cash flows,3.9683755137356695
771,award,3.966666666666667
772,additional financing,3.9624893435635125
773,fixed collimator,3.96
774,tomotherapy systems,3.9547038327526134
775,50% convertible note,3.9545606975184437
776,fasb approved,3.9545454545454546
777,cyberknife system,3.952625570776256
778,potential customer,3.9520123839009287
779,75% convertible notes,3.943836573157956
780,50% convertible notes,3.943836573157956
781,convertible notes,3.943836573157956
782,disclosures,3.9404761904761907
783,operating assets,3.9402898550724634
784,institutions,3.9401709401709404
785,significant uncertainties,3.93859649122807
786,annual report,3.9375
787,unique benefits,3.9375
788,current quarter,3.933344251555847
789,minimum deposit,3.9333333333333336
790,accompanying notes,3.9297520661157024
791,75% senior notes,3.9297520661157024
792,term success,3.927835051546392
793,statements,3.9259259259259256
794,events,3.9230769230769234
795,subsequent events,3.9230769230769234
796,significant impact,3.9224674589700057
797,related upgrades,3.9222417840375585
798,revenue recognition,3.9189486937362292
799,generally spans,3.918918918918919
800,governed generally,3.918918918918919
801,generally governed,3.918918918918919
802,cost basis,3.918103448275862
803,adverse determination,3.916666666666667
804,annual periods,3.916666666666667
805,contract,3.915492957746479
806,executed contract,3.915492957746479
807,written contract,3.915492957746479
808,party evidence,3.9134615384615383
809,wider range,3.9130434782608696
810,wide range,3.9130434782608696
811,agreement,3.9117147707979623
812,general requirements,3.905913978494624
813,lease obligations,3.9055555555555554
814,anticipated cash,3.902277432712215
815,tomotherapy system,3.8988095238095237
816,customer,3.8968327899394506
817,revenue,3.8960728767427653
818,segment,3.8909090909090907
819,numerous factors,3.888888888888889
820,foreign earnings,3.888888888888889
821,services,3.8874139626352013
822,share price,3.8870967741935485
823,cash equivalents,3.8813715093672676
824,future results,3.8806949806949804
825,initial application,3.877049180327869
826,large tumors,3.875
827,large hospital,3.875
828,quarterly report,3.8693181818181817
829,collection efforts,3.8686868686868685
830,strategic transactions,3.867924528301887
831,transactions,3.867924528301887
832,total number,3.8635477582846005
833,early adopt,3.8603896103896105
834,related repurchase,3.8597417840375585
835,net proceeds,3.8581571230128104
836,reports profit,3.857142857142857
837,orderly transaction,3.857142857142857
838,tomotherapy,3.857142857142857
839,potential impairment,3.8566176470588234
840,future operations,3.8561101549053354
841,recognize assets,3.8533333333333335
842,contractual maturities,3.8491786958685914
843,current guidance,3.8488372093023258
844,incise mlc,3.8484848484848486
845,south america,3.8461538461538463
846,statements,3.844844844844845
847,debt securities,3.84375
848,accrued interest,3.8431372549019605
849,revenue transactions,3.8424287775936716
850,fiscal year,3.842020202020202
851,fiscal year,3.842020202020202
852,fiscal year,3.842020202020202
853,fiscal year,3.842020202020202
854,fiscal year,3.842020202020202
855,fiscal year,3.842020202020202
856,fiscal year,3.842020202020202
857,fiscal year,3.842020202020202
858,accounts,3.8389380530973454
859,continued adoption,3.8378378378378377
860,financing receivables,3.8269151138716353
861,notional amounts,3.8235294117647056
862,liquidity requirements,3.8225806451612905
863,deferred revenue,3.8223303362483065
864,product revenue,3.8217264715140074
865,equity investments,3.8213393303348324
866,unspecified claim,3.8181818181818183
867,year criteria,3.8177777777777777
868,separate ruling,3.8166666666666664
869,order growth,3.816326530612245
870,fixed assets,3.8133333333333335
871,foreign operations,3.8132530120481927
872,omitted pursuant,3.806451612903226
873,development project,3.803030303030303
874,measurement date,3.7970627503337786
875,partially offset,3.7964232488822653
876,outpatient basis,3.793103448275862
877,nonrecurring basis,3.793103448275862
878,accuray incorporated,3.7888888888888888
879,losses,3.7875
880,company classifies,3.784016636957814
881,company reviews,3.784016636957814
882,actual results,3.7822822822822824
883,amounts,3.781862745098039
884,derived principally,3.7777777777777777
885,licensing agreement,3.7719298245614032
886,agency securities,3.760416666666667
887,securities,3.760416666666667
888,factors,3.7598566308243724
889,cash receipts,3.7594202898550724
890,contractual obligations,3.7590702947845807
891,issuance,3.758687675372329
892,amortization expense,3.758009708737864
893,reporting periods,3.757575757575758
894,price,3.757467144563919
895,revenue,3.7522820270695627
896,decreased installation,3.752173913043478
897,sale transactions,3.750277469478357
898,continued advances,3.75
899,vendor,3.75
900,credit quality,3.7492537313432837
901,surgical treatments,3.742857142857143
902,integral part,3.7391304347826084
903,current liabilities,3.7311901504787963
904,counts,3.730769230769231
905,consigned parts,3.730769230769231
906,system,3.7291666666666665
907,cash,3.7260869565217387
908,cowealth,3.7241379310344827
909,cancer patients,3.723076923076923
910,systems,3.722560975609756
911,increased demand,3.7205882352941178
912,year deferral,3.717777777777778
913,historical fact,3.7142857142857144
914,maintaining fda,3.7142857142857144
915,installation services,3.707729468599034
916,financial liabilities,3.7058823529411766
917,disclosure requirements,3.6975806451612905
918,commission expense,3.6959726717008268
919,fundamental change,3.6938775510204085
920,market capitalization,3.6919831223628696
921,financial covenants,3.6919504643962853
922,3million provided,3.68984962406015
923,report,3.6875
924,judgments,3.6875
925,tender awards,3.6875
926,contingent assets,3.6866666666666665
927,active markets,3.678571428571429
928,tumor types,3.666666666666667
929,current operations,3.6620902213505184
930,customer,3.6578947368421053
931,customer licensees,3.6578947368421053
932,fewer age,3.6493023255813952
933,intercompany balances,3.6470588235294117
934,variable consideration,3.6454545454545455
935,anticipated risks,3.642857142857143
936,sale securities,3.642769607843137
937,revenue,3.6411709159584515
938,development research,3.6363636363636367
939,billings,3.6358543417366946
940,orders,3.632129854368932
941,sales,3.629032258064516
942,sales organization,3.629032258064516
943,sales agents,3.629032258064516
944,sales commissions,3.629032258064516
945,installation revenue,3.626678162335263
946,ongoing basis,3.626436781609195
947,commission amount,3.625125125125125
948,precisely conform,3.625
949,established reliability,3.625
950,location,3.625
951,investments,3.6238471673254278
952,statements,3.622895622895623
953,accuray breached,3.6222222222222222
954,generated primarily,3.61736150770988
955,revenue,3.6173613921489274
956,liabilities,3.617094725214029
957,treatment sessions,3.617021276595745
958,treatment room,3.617021276595745
959,order volume,3.6163265306122447
960,material losses,3.6136904761904765
961,tomotherapy,3.607142857142857
962,amount,3.606606606606607
963,amortized cost,3.6032608695652173
964,considered aged,3.6032388663967616
965,damages,3.601408450704225
966,customer receivables,3.6007518796992484
967,permits,3.6
968,training points,3.6
969,training revenues,3.6
970,customer facilities,3.5953947368421053
971,table sets,3.5952380952380953
972,table,3.5952380952380953
973,table,3.5952380952380953
974,table,3.5952380952380953
975,distributor orders,3.5926953305594083
976,calendar quarter,3.584507042253521
977,owned subsidiaries,3.583333333333333
978,key estimates,3.583333333333333
979,administrative general,3.583333333333333
980,terms,3.5829059829059826
981,distributor agreement,3.581453634085213
982,training revenue,3.5745042492917847
983,liability component,3.5714285714285716
984,revenue,3.5627395434094318
985,fully settled,3.5625
986,primarily driven,3.5585379782981152
987,service offices,3.55663430420712
988,deemed essential,3.5555555555555554
989,parties,3.5555555555555554
990,treatment facilities,3.554521276595745
991,assumptions,3.554112554112554
992,prepayment premium,3.552631578947368
993,assumptions,3.5510204081632653
994,backlog,3.547222222222222
995,update forward,3.547169811320755
996,increased cancellations,3.542016806722689
997,fair market,3.540022338049144
998,terms,3.5384615384615383
999,level2 inputs,3.5384615384615383
1000,party analyst,3.5384615384615383
1001,permitted starting,3.533333333333333
1002,maturity date,3.5292056074766354
1003,lessee,3.529126213592233
1004,debt,3.5277777777777777
1005,continued amortization,3.525
1006,recorded directly,3.515625
1007,difference,3.515625
1008,marketing selling,3.5132275132275135
1009,business,3.5125
1010,business strategy,3.5125
1011,fewer cancellations,3.5114285714285716
1012,goods,3.5
1013,completed acquisitions,3.5
1014,readily accessible,3.5
1015,entire carrying,3.5
1016,earlier repurchased,3.5
1017,dividend distribution,3.5
1018,item,3.5
1019,risks,3.5
1020,tumors,3.5
1021,physician,3.5
1022,adequately treat,3.5
1023,government entity,3.5
1024,written amendment,3.5
1025,assurance,3.5
1026,adequate liquidity,3.5
1027,guidance simplifies,3.5
1028,offsetting gain,3.5
1029,trading purposes,3.5
1030,expiration dates,3.5
1031,responsibility,3.5
1032,signed contract,3.48692152917505
1033,net age,3.486814287303883
1034,subsequent material,3.4761904761904763
1035,distributor channels,3.4761904761904763
1036,orders,3.473647711511789
1037,goodwill,3.4716599190283404
1038,company,3.471647664211482
1039,company,3.471647664211482
1040,discount rate,3.4625474083438683
1041,4million related,3.456964006259781
1042,dismissal,3.4545454545454546
1043,primarily denominated,3.4457928802588995
1044,greater number,3.4444444444444446
1045,values,3.4444444444444446
1046,7 million related,3.4412314595537827
1047,0 million related,3.4412314595537827
1048,6 million related,3.4412314595537827
1049,net property,3.438802284303133
1050,cowealth,3.4384236453201966
1051,contractual terms,3.436420722135008
1052,temporarily impaired,3.428571428571429
1053,government securities,3.4270833333333335
1054,litigation settlements,3.4263157894736844
1055,operating results,3.4247943595769685
1056,amounts,3.423529411764706
1057,icc ruled,3.4210526315789473
1058,higher percentage,3.4105263157894736
1059,factors,3.409436834094368
1060,cash items,3.4094202898550723
1061,fiscal quarter,3.4087494664959452
1062,customer,3.4078947368421053
1063,sufficient number,3.4074074074074074
1064,conversion option,3.4067887931034484
1065,orders,3.4022191400832176
1066,summary judgment,3.390756302521009
1067,backlog criteria,3.388888888888889
1068,undistributed earnings,3.388888888888889
1069,dollar,3.3870967741935485
1070,management,3.3864468864468864
1071,systems,3.3854397634885443
1072,time,3.3848739495798315
1073,reasonable possibility,3.375
1074,variables,3.370967741935484
1075,term investments,3.369864037053638
1076,treatment,3.367021276595745
1077,damages,3.3666666666666667
1078,damages,3.3666666666666667
1079,identical assets,3.3533333333333335
1080,debt discount,3.3511904761904763
1081,measure fair,3.348039215686274
1082,recorded based,3.347483407079646
1083,4million due,3.3441734417344176
1084,signed contracts,3.344155844155844
1085,higher technology,3.342857142857143
1086,existing equipment,3.342553191489362
1087,company designs,3.3395721925133692
1088,company,3.3395721925133692
1089,company records,3.3395721925133692
1090,company,3.3395721925133692
1091,company,3.3395721925133692
1092,company,3.3395721925133692
1093,company,3.3395721925133692
1094,company,3.3395721925133692
1095,company,3.3395721925133692
1096,company,3.3395721925133692
1097,company,3.3395721925133692
1098,company,3.3395721925133692
1099,traditional surgery,3.333333333333333
1100,disease,3.333333333333333
1101,management,3.3318250377073904
1102,8 million due,3.3284408950284194
1103,5 million due,3.3284408950284194
1104,4 million due,3.3284408950284194
1105,6 million due,3.3284408950284194
1106,9 million due,3.3284408950284194
1107,3 million due,3.3284408950284194
1108,2 million due,3.3284408950284194
1109,0 million due,3.3284408950284194
1110,7 million due,3.3284408950284194
1111,1 million due,3.3284408950284194
1112,premium shares,3.324561403508772
1113,sale investments,3.324381926683717
1114,share amounts,3.3235294117647056
1115,confidential information,3.3235294117647056
1116,due february1,3.3219512195121954
1117,forward contracts,3.3198970840480273
1118,adversely affect,3.3125
1119,access,3.3125
1120,overview products,3.3125
1121,generally determined,3.311075781664017
1122,small portion,3.310344827586207
1123,credit analysis,3.3092537313432837
1124,qibs pursuant,3.306451612903226
1125,recognized concurrent,3.3
1126,recognized concurrently,3.3
1127,company,3.2979055258467023
1128,1million related,3.2972417840375585
1129,extent,3.287878787878788
1130,pending adoption,3.2822822822822824
1131,excluded due,3.2798459563543005
1132,developed countries,3.2777777777777777
1133,developing countries,3.2777777777777777
1134,revenue,3.274504249291785
1135,revenue,3.274504249291785
1136,loss contingencies,3.273015873015873
1137,recent years,3.2608695652173916
1138,specific patient,3.2592592592592595
1139,management,3.2592147435897436
1140,participating holders,3.2531645569620253
1141,cowealth litigation,3.250453720508167
1142,suit,3.25
1143,expired points,3.25
1144,cash payments,3.2492162082224194
1145,hospitals,3.2348336594911937
1146,slight increase,3.2347294938917974
1147,ins,3.2303030303030305
1148,contract,3.227992957746479
1149,bifurcation,3.2272727272727275
1150,slight decrease,3.212820512820513
1151,large research,3.208333333333333
1152,company transactions,3.207496720815256
1153,cumulative effect,3.2
1154,time,3.2
1155,loss information,3.196545284780579
1156,refinance approximately $70,3.1913043478260867
1157,totaling approximately 3,3.1913043478260867
1158,totaling approximately 13,3.1913043478260867
1159,backlog,3.188888888888889
1160,payments,3.186765615337044
1161,periods,3.166666666666667
1162,product portion,3.157567049808429
1163,redemption date,3.1542056074766354
1164,company,3.1520721925133692
1165,binding arbitration,3.141025641025641
1166,primarily attributable,3.129126213592233
1167,segment information,3.123529411764706
1168,dismissal,3.121212121212121
1169,ins,3.1166666666666663
1170,6 commitments,3.107142857142857
1171,asfollows,3.1
1172,fiscal years,3.085111989459816
1173,customers,3.0825688073394497
1174,impact backlog,3.0727598566308245
1175,accrued liabilities,3.0588235294117645
1176,cash,3.0451345755693584
1177,2million shares,3.0311890838206628
1178,remaining change,3.0272108843537415
1179,infringement indemnification,3.0
1180,company,2.9866310160427805
1181,company,2.9824293353705116
1182,impairment,2.9625
1183,material impact,2.9600614439324118
1184,goodwill impairment,2.957236842105263
1185,compliance levels,2.9523809523809526
1186,investments,2.942028985507246
1187,company,2.927807486631016
1188,icc released,2.9210526315789473
1189,company,2.9110007639419404
1190,recorded goodwill,2.910361842105263
1191,annum equal,2.905982905982906
1192,company,2.9020721925133692
1193,company,2.8951277480689246
1194,components,2.8924485125858124
1195,backlog,2.888888888888889
1196,case basis,2.884012539184953
1197,headcount,2.8827838827838828
1198,month volatility,2.880952380952381
1199,reasons,2.8776908023483365
1200,9million shares,2.8552631578947367
1201,company,2.8551971925133692
1202,permitted beginning,2.8470588235294114
1203,company,2.8395721925133692
1204,considered equivalent,2.838815789473684
1205,fair presentation,2.8361344537815123
1206,investments,2.826644370122631
1207,09 defines,2.8181818181818183
1208,repurchase approximately $63,2.8163043478260867
1209,months,2.8130841121495327
1210,12 months,2.8130841121495327
1211,end customer,2.800751879699248
1212,parties,2.7936507936507935
1213,closing,2.793103448275862
1214,09is,2.787878787878788
1215,company,2.7840166369578134
1216,impact,2.7381082558775285
1217,remanded claims,2.738095238095238
1218,3 million driven,2.7359014402221065
1219,backlog adjustment,2.731746031746032
1220,company,2.7317290552584668
1221,security deposits,2.7301587301587302
1222,million reduction,2.728228805951007
1223,company,2.7205245734657497
1224,age,2.7093023255813953
1225,backlog,2.707936507936508
1226,accuray customers,2.7047910295616715
1227,impairment annually,2.6801470588235294
1228,group,2.6666666666666665
1229,payments,2.6564625850340136
1230,risks,2.65625
1231,inability,2.6538812785388126
1232,company,2.625286478227655
1233,outs,2.612399193548387
1234,aggregate,2.6037735849056602
1235,tax,2.5476190476190474
1236,payment,2.5384615384615383
1237,remaining approximately $36,2.52463768115942
1238,accounting,2.5128205128205128
1239,software,2.5
1240,fasb,2.5
1241,modified,2.5
1242,income,2.493333333333333
1243,time,2.487878787878788
1244,increased,2.4705882352941178
1245,estimates,2.4647435897435894
1246,total,2.456140350877193
1247,policies,2.45
1248,present supplier,2.4450549450549453
1249,significant,2.43859649122807
1250,december31,2.421965317919075
1251,march31,2.4057142857142857
1252,leading,2.4
1253,principal,2.3986486486486487
1254,radiation,2.3896103896103895
1255,price,2.3870967741935485
1256,equity,2.3793103448275863
1257,trade,2.3684210526315788
1258,performance,2.3548387096774195
1259,current,2.3488372093023258
1260,observable,2.3333333333333335
1261,reply,2.3333333333333335
1262,resulted,2.3333333333333335
1263,lower,2.3333333333333335
1264,underlying,2.2857142857142856
1265,compensation,2.2790697674418605
1266,net,2.277511961722488
1267,stock,2.2756410256410255
1268,million increase,2.274552502741355
1269,september30,2.267605633802817
1270,million decrease,2.2526435216700706
1271,arrangements,2.25
1272,licenses,2.25
1273,conditions,2.25
1274,accounts,2.2389380530973453
1275,4 million compared,2.2357294415980955
1276,2 million compared,2.2357294415980955
1277,related,2.2347417840375585
1278,conversion,2.234375
1279,expense,2.233009708737864
1280,condensed,2.230769230769231
1281,alleging,2.230769230769231
1282,service,2.2233009708737863
1283,process,2.2222222222222223
1284,judgment,2.2142857142857144
1285,elect,2.2142857142857144
1286,represent,2.2142857142857144
1287,arbitrator,2.2
1288,higher,2.2
1289,accruals,2.2
1290,component,2.1964285714285716
1291,rate,2.1946902654867255
1292,prior,2.1848739495798317
1293,incorporated,2.1666666666666665
1294,interest,2.1666666666666665
1295,license,2.1666666666666665
1296,amount,2.1621621621621623
1297,costs,2.1517857142857144
1298,credit,2.1492537313432836
1299,expenses,2.145631067961165
1300,adjustments,2.142857142857143
1301,measurement,2.142857142857143
1302,losses,2.1375
1303,issued,2.1320754716981134
1304,secured,2.1285714285714286
1305,cost,2.125
1306,due,2.1219512195121952
1307,offering,2.119047619047619
1308,orders,2.116504854368932
1309,finance,2.111111111111111
1310,agreement,2.1052631578947367
1311,inventory,2.1052631578947367
1312,decreased,2.1
1313,systems,2.097560975609756
1314,accrual,2.090909090909091
1315,operating,2.0869565217391304
1316,differ,2.0869565217391304
1317,debt,2.0833333333333335
1318,funds,2.0833333333333335
1319,additional $2,2.0784313725490198
1320,consisted,2.076923076923077
1321,period,2.07
1322,services,2.0555555555555554
1323,projects,2.0476190476190474
1324,lease,2.0444444444444443
1325,system,2.0416666666666665
1326,greater,2.037037037037037
1327,primarily,2.029126213592233
1328,market,2.0253164556962027
1329,year,2.017777777777778
1330,loan,2.0144927536231885
1331,convertible,2.0140845070422535
1332,tumors,2.0
1333,reflect,2.0
1334,methods,2.0
1335,revenues,2.0
1336,basic,2.0
1337,investment,2.0
1338,directly,2.0
1339,success,2.0
1340,belief,2.0
1341,obligation,2.0
1342,sells,2.0
1343,designed,2.0
1344,specific,2.0
1345,radiosurgery,2.0
1346,advanced,2.0
1347,seriessystems,2.0
1348,normal,2.0
1349,place,2.0
1350,fund,2.0
1351,sufficient,2.0
1352,deemed,2.0
1353,radixact,2.0
1354,revenue,1.9745042492917848
1355,paid,1.9666666666666666
1356,award,1.9666666666666666
1357,fixed,1.96
1358,includes,1.9583333333333333
1359,maturities,1.951219512195122
1360,depreciation,1.9473684210526316
1361,values,1.9444444444444444
1362,recognition,1.9444444444444444
1363,receivables,1.9428571428571428
1364,note,1.9404761904761905
1365,note 9,1.9404761904761905
1366,note 1,1.9404761904761905
1367,note 5,1.9404761904761905
1368,note 7,1.9404761904761905
1369,note 8,1.9404761904761905
1370,combination,1.9375
1371,benefits,1.9375
1372,facilities,1.9375
1373,notes,1.9297520661157024
1374,term,1.9278350515463918
1375,issuance,1.9268292682926829
1376,statements,1.9259259259259258
1377,effective,1.9242424242424243
1378,resulting,1.9215686274509804
1379,generally,1.9189189189189189
1380,plans,1.9166666666666667
1381,contract,1.9154929577464788
1382,range,1.9130434782608696
1383,asu,1.9111111111111112
1384,cyberknife,1.9109589041095891
1385,estimable,1.9090909090909092
1386,estimated,1.9
1387,settlements,1.9
1388,contractual,1.8979591836734695
1389,allocated,1.8888888888888888
1390,factors,1.8888888888888888
1391,restrictions,1.8888888888888888
1392,financing,1.8840579710144927
1393,sale,1.8823529411764706
1394,maturity,1.875
1395,large,1.875
1396,loss,1.873015873015873
1397,include,1.8709677419354838
1398,transactions,1.8679245283018868
1399,obligations,1.8611111111111112
1400,assumptions,1.8571428571428572
1401,tomotherapy,1.8571428571428572
1402,request,1.8571428571428572
1403,assessing,1.8571428571428572
1404,transaction,1.8571428571428572
1405,profit,1.8571428571428572
1406,assets,1.8533333333333333
1407,mlc,1.8484848484848484
1408,deferred,1.8478260869565217
1409,product,1.8472222222222223
1410,america,1.8461538461538463
1411,settlement,1.84
1412,leases,1.84
1413,adoption,1.837837837837838
1414,based,1.831858407079646
1415,fiscal 2019,1.8242424242424242
1416,fiscal 2018,1.8242424242424242
1417,fiscal 2016,1.8242424242424242
1418,fiscal 2015,1.8242424242424242
1419,fiscal 2013,1.8242424242424242
1420,fiscal 2017,1.8242424242424242
1421,fiscal 2011,1.8242424242424242
1422,retrospective,1.8235294117647058
1423,amounts,1.8235294117647058
1424,claim,1.8181818181818181
1425,order,1.816326530612245
1426,held,1.8125
1427,pursuant,1.8064516129032258
1428,segment,1.8
1429,criteria,1.8
1430,volume,1.8
1431,fee,1.8
1432,basis,1.793103448275862
1433,currencies,1.7857142857142858
1434,derived,1.7777777777777777
1435,collection,1.7777777777777777
1436,contracts,1.7727272727272727
1437,shares,1.7719298245614035
1438,5548 shares,1.7719298245614035
1439,6877 shares,1.7719298245614035
1440,estimate,1.7692307692307692
1441,inputs,1.7692307692307692
1442,level2,1.7692307692307692
1443,standards,1.7692307692307692
1444,provisions,1.7692307692307692
1445,offset,1.7636363636363637
1446,2015 offset,1.7636363636363637
1447,components,1.7608695652173914
1448,securities,1.7604166666666667
1449,cash,1.7594202898550724
1450,filed,1.75
1451,deliver,1.75
1452,efficient,1.75
1453,utilization,1.75
1454,advances,1.75
1455,base,1.75
1456,management,1.7435897435897436
1457,treatments,1.7428571428571429
1458,part,1.7391304347826086
1459,parts,1.7307692307692308
1460,cowealth,1.7241379310344827
1461,fact,1.7142857142857142
1462,billings,1.7142857142857142
1463,applied,1.7142857142857142
1464,fda,1.7142857142857142
1465,hospitals,1.7142857142857142
1466,deferral,1.7
1467,made,1.696969696969697
1468,change,1.6938775510204083
1469,headcount,1.6923076923076923
1470,upgrades,1.6875
1471,awards,1.6875
1472,report,1.6875
1473,markets,1.6785714285714286
1474,accrued,1.6764705882352942
1475,gaap,1.6666666666666667
1476,post,1.6666666666666667
1477,dilutive,1.6666666666666667
1478,effects,1.6666666666666667
1479,alternative,1.6666666666666667
1480,tumor,1.6666666666666667
1481,government,1.6666666666666667
1482,periods,1.6666666666666667
1483,simplifying,1.6666666666666667
1484,guarantees,1.6666666666666667
1485,extinguishment,1.6666666666666667
1486,volatility,1.6666666666666667
1487,customer,1.6578947368421053
1488,date,1.6542056074766356
1489,installation,1.6521739130434783
1490,2015 included,1.65
1491,included,1.65
1492,items,1.65
1493,2016 included,1.65
1494,balances,1.6470588235294117
1495,beginning,1.6470588235294117
1496,pcs,1.6428571428571428
1497,intends,1.6428571428571428
1498,7million,1.6363636363636365
1499,sales,1.6290322580645162
1500,established,1.625
1501,obtain,1.625
1502,earlier,1.625
1503,repurchase,1.625
1504,location,1.625
1505,conform,1.625
1506,accuray,1.6222222222222222
1507,treatment,1.6170212765957446
1508,inventories,1.6153846153846154
1509,training,1.6
1510,stockholders,1.6
1511,reported,1.6
1512,quality,1.6
1513,rated,1.6
1514,obtained,1.6
1515,asfollows,1.6
1516,table,1.5952380952380953
1517,patients,1.5897435897435896
1518,backlog,1.5888888888888888
1519,generated,1.588235294117647
1520,believes,1.588235294117647
1521,quarter,1.5845070422535212
1522,subsidiaries,1.5833333333333333
1523,general,1.5833333333333333
1524,proceeds,1.5806451612903225
1525,purchase,1.5789473684210527
1526,awarded,1.5714285714285714
1527,care,1.5714285714285714
1528,signed,1.5714285714285714
1529,impairment,1.5625
1530,settled,1.5625
1531,exceed,1.5555555555555556
1532,parties,1.5555555555555556
1533,charge,1.5555555555555556
1534,essential,1.5555555555555556
1535,considers,1.5555555555555556
1536,premium,1.5526315789473684
1537,sell,1.5517241379310345
1538,forward,1.5471698113207548
1539,consideration,1.5454545454545454
1540,series,1.5454545454545454
1541,terms,1.5384615384615385
1542,party,1.5384615384615385
1543,deposit,1.5333333333333334
1544,expected,1.53125
1545,driven,1.5294117647058822
1546,litigation,1.5263157894736843
1547,considered,1.5263157894736843
1548,amortization,1.525
1549,reduction,1.5217391304347827
1550,including,1.5205479452054795
1551,asset,1.5172413793103448
1552,recorded,1.515625
1553,fair,1.5147058823529411
1554,business,1.5125
1555,item,1.5
1556,goods,1.5
1557,share,1.5
1558,risks,1.5
1559,times,1.5
1560,typically,1.5
1561,identical,1.5
1562,readily,1.5
1563,presented,1.5
1564,suit,1.5
1565,counts,1.5
1566,remanded,1.5
1567,application,1.5
1568,purposes,1.5
1569,infringement,1.5
1570,provide,1.5
1571,indemnification,1.5
1572,qibs,1.5
1573,redemption,1.5
1574,options,1.5
1575,carrying,1.5
1576,guidance,1.5
1577,anticipates,1.5
1578,uncertainties,1.5
1579,treat,1.5
1580,expect,1.5
1581,treating,1.5
1582,expiration,1.5
1583,distribution,1.5
1584,additions,1.5
1585,acquisitions,1.5
1586,evaluate,1.5
1587,item,1.5
1588,lessee,1.5
1589,variables,1.5
1590,liquidity,1.5
1591,gain,1.5
1592,09is,1.5
1593,20 item,1.5
1594,amendment,1.5
1595,released,1.5
1596,shift,1.5
1597,hiring,1.5
1598,project,1.5
1599,payments,1.489795918367347
1600,impact,1.4838709677419355
1601,amortized,1.4782608695652173
1602,material,1.4761904761904763
1603,probable,1.4761904761904763
1604,distributor,1.4761904761904763
1605,ins,1.4666666666666666
1606,commission,1.462962962962963
1607,valuation,1.4615384615384615
1608,annum,1.4615384615384615
1609,dismissal,1.4545454545454546
1610,approved,1.4545454545454546
1611,security,1.4444444444444444
1612,pending,1.4444444444444444
1613,equal,1.4444444444444444
1614,repaid,1.4444444444444444
1615,repaid $5,1.4444444444444444
1616,investments,1.4420289855072463
1617,june30,1.4406779661016949
1618,fluctuations,1.434782608695652
1619,adopt,1.4285714285714286
1620,matters,1.4285714285714286
1621,impaired,1.4285714285714286
1622,icc,1.4210526315789473
1623,determination,1.4166666666666667
1624,denominated,1.4166666666666667
1625,number,1.4074074074074074
1626,sold,1.4
1627,contingencies,1.4
1628,october29,1.4
1629,ruling,1.4
1630,noted,1.4
1631,exist,1.4
1632,collections,1.4
1633,tomohda,1.4
1634,goodwill,1.394736842105263
1635,determined,1.392156862745098
1636,assessment,1.391304347826087
1637,earnings,1.3888888888888888
1638,dollar,1.3870967741935485
1639,classified,1.3846153846153846
1640,liabilities,1.3823529411764706
1641,performed,1.380952380952381
1642,liability,1.375
1643,disclosure,1.375
1644,reasonable,1.375
1645,selling,1.3703703703703705
1646,26 selling,1.3703703703703705
1647,covenants,1.368421052631579
1648,damages,1.3666666666666667
1649,reasons,1.3571428571428572
1650,upgrade,1.3571428571428572
1651,company,1.339572192513369
1652,results,1.337837837837838
1653,body,1.3333333333333333
1654,offices,1.3333333333333333
1655,estimating,1.3333333333333333
1656,occur,1.3333333333333333
1657,amended,1.3333333333333333
1658,remaining $44,1.3333333333333333
1659,remaining $47,1.3333333333333333
1660,surgery,1.3333333333333333
1661,disease,1.3333333333333333
1662,research,1.3333333333333333
1663,remaining $3,1.3333333333333333
1664,remaining $4,1.3333333333333333
1665,write,1.3333333333333333
1666,remaining 3,1.3333333333333333
1667,remaining $2,1.3333333333333333
1668,customary,1.3333333333333333
1669,information,1.3235294117647058
1670,presentation,1.3214285714285714
1671,3million,1.3214285714285714
1672,operations,1.3132530120481927
1673,affect,1.3125
1674,products,1.3125
1675,met,1.3125
1676,equivalent,1.3125
1677,improve,1.3125
1678,judgments,1.3125
1679,portion,1.3103448275862069
1680,arbitration,1.3076923076923077
1681,09 recognized,1.3
1682,recognized,1.3
1683,required,1.2878787878787878
1684,deposits,1.2857142857142858
1685,added,1.2857142857142858
1686,levels,1.2857142857142858
1687,pay,1.2857142857142858
1688,countries,1.2777777777777777
1689,adopted,1.2727272727272727
1690,discount,1.2678571428571428
1691,limited,1.2666666666666666
1692,years,1.2608695652173914
1693,5 years,1.2608695652173914
1694,patient,1.2592592592592593
1695,2million,1.2592592592592593
1696,make,1.2564102564102564
1697,long,1.2542372881355932
1698,holders,1.2531645569620253
1699,demand,1.25
1700,august2016,1.25
1701,bonuses,1.25
1702,amendments,1.25
1703,expired,1.25
1704,tomoh,1.25
1705,tomohd,1.25
1706,claims,1.2380952380952381
1707,allowance,1.2307692307692308
1708,present,1.2307692307692308
1709,require,1.2272727272727273
1710,4million,1.2222222222222223
1711,supplier,1.2142857142857142
1712,month,1.2142857142857142
1713,1 month,1.2142857142857142
1714,percentage,1.2105263157894737
1715,age,1.2093023255813953
1716,estimates,1.2083333333333333
1717,defined,1.2083333333333333
1718,5 million,1.2064896755162242
1719,1 million,1.2064896755162242
1720,0 million,1.2064896755162242
1721,4 million,1.2064896755162242
1722,6 million,1.2064896755162242
1723,3 million,1.2064896755162242
1724,2 million,1.2064896755162242
1725,9 million,1.2064896755162242
1726,8 million,1.2064896755162242
1727,7 million,1.2064896755162242
1728,permitted,1.2
1729,effect,1.2
1730,6million,1.2
1731,time,1.2
1732,february1,1.2
1733,life,1.2
1734,march2016,1.2
1735,complex,1.2
1736,0million,1.1935483870967742
1737,approximately $170,1.191304347826087
1738,approximately $35,1.191304347826087
1739,approximately $5,1.191304347826087
1740,approximately $96,1.191304347826087
1741,approximately $9,1.191304347826087
1742,approximately $110,1.191304347826087
1743,approximately $70,1.191304347826087
1744,approximately $0,1.191304347826087
1745,approximately $44,1.191304347826087
1746,approximately $36,1.191304347826087
1747,approximately $1,1.191304347826087
1748,approximately $55,1.191304347826087
1749,approximately $65,1.191304347826087
1750,approximately,1.191304347826087
1751,approximately $37,1.191304347826087
1752,approximately 10,1.191304347826087
1753,decreases,1.1904761904761905
1754,summary,1.1764705882352942
1755,option,1.1724137931034482
1756,received,1.1666666666666667
1757,delivery,1.1666666666666667
1758,commitments,1.1666666666666667
1759,dilution,1.1666666666666667
1760,scope,1.1666666666666667
1761,property,1.1612903225806452
1762,analysis,1.16
1763,excluded,1.1578947368421053
1764,discussed,1.15625
1765,submitted,1.1428571428571428
1766,adjustment,1.1428571428571428
1767,end,1.1428571428571428
1768,expects,1.1428571428571428
1769,technology,1.1428571428571428
1770,letter,1.1428571428571428
1771,delays,1.1428571428571428
1772,inability,1.1333333333333333
1773,subject,1.131578947368421
1774,convert,1.119047619047619
1775,annually,1.1176470588235294
1776,attributable,1.1
1777,8million,1.1
1778,outs,1.096774193548387
1779,case,1.0909090909090908
1780,9million,1.0833333333333333
1781,customers,1.0825688073394495
1782,cancellations,1.0714285714285714
1783,increase,1.068062827225131
1784,1million,1.0625
1785,january2016,1.0555555555555556
1786,standard,1.0512820512820513
1787,decrease,1.0461538461538462
1788,event,1.0434782608695652
1789,equipment,1.0425531914893618
1790,compared,1.0292397660818713
1791,2016 compared,1.0292397660818713
1792,5million,1.0238095238095237
1793,thousands,1.0
1794,par,1.0
1795,unaudited,1.0
1796,june,1.0
1797,delaware,1.0
1798,sunnyvale,1.0
1799,california,1.0
1800,develops,1.0
1801,switzerland,1.0
1802,china,1.0
1803,japan,1.0
1804,conducts,1.0
1805,principles,1.0
1806,consolidation,1.0
1807,wholly,1.0
1808,eliminated,1.0
1809,prepared,1.0
1810,accordance,1.0
1811,sec,1.0
1812,opinion,1.0
1813,read,1.0
1814,conjunction,1.0
1815,form10,1.0
1816,august28,1.0
1817,topic,1.0
1818,supersede,1.0
1819,transferred,1.0
1820,reflects,1.0
1821,achieve,1.0
1822,allocating,1.0
1823,july9,1.0
1824,entities,1.0
1825,providing,1.0
1826,selected,1.0
1827,evaluating,1.0
1828,preparation,1.0
1829,conformity,1.0
1830,recoverability,1.0
1831,deposited,1.0
1832,experienced,1.0
1833,exposed,1.0
1834,10%,1.0
1835,11%,1.0
1836,collateralized,1.0
1837,charged,1.0
1838,unsuccessful,1.0
1839,cases,1.0
1840,unable,1.0
1841,find,1.0
1842,sources,1.0
1843,vsoe,1.0
1844,tpe,1.0
1845,besp,1.0
1846,majority,1.0
1847,responsible,1.0
1848,acceptance,1.0
1849,assuming,1.0
1850,call,1.0
1851,functionality,1.0
1852,expensed,1.0
1853,incurred,1.0
1854,computed,1.0
1855,reconciliation,1.0
1856,numerator,1.0
1857,denominator,1.0
1858,calculation,1.0
1859,vesting,1.0
1860,rsu,1.0
1861,msu,1.0
1862,psu,1.0
1863,espp,1.0
1864,computation,1.0
1865,anti,1.0
1866,additionally,1.0
1867,inclusion,1.0
1868,intent,1.0
1869,settle,1.0
1870,vary,1.0
1871,operates,1.0
1872,consisting,1.0
1873,inthousands,1.0
1874,continue,1.0
1875,monitor,1.0
1876,indicators,1.0
1877,identify,1.0
1878,definite,1.0
1879,certificates,1.0
1880,short,1.0
1881,accumulated,1.0
1882,transfer,1.0
1883,hierarchy,1.0
1884,level,1.0
1885,indirectly,1.0
1886,corroborated,1.0
1887,relied,1.0
1888,determine,1.0
1889,recovery,1.0
1890,indication,1.0
1891,recover,1.0
1892,measured,1.0
1893,ordinary,1.0
1894,involved,1.0
1895,provision,1.0
1896,respect,1.0
1897,individually,1.0
1898,control,1.0
1899,prove,1.0
1900,incorrect,1.0
1901,april28,1.0
1902,theories,1.0
1903,injury,1.0
1904,purchases,1.0
1905,dismiss,1.0
1906,august29,1.0
1907,motion,1.0
1908,may21,1.0
1909,specificity,1.0
1910,prejudice,1.0
1911,hearing,1.0
1912,september20,1.0
1913,favor,1.0
1914,december5,1.0
1915,december22,1.0
1916,affirmed,1.0
1917,confirmed,1.0
1918,february27,1.0
1919,misappropriated,1.0
1920,answer,1.0
1921,counterclaim,1.0
1922,may12,1.0
1923,june27,1.0
1924,january26,1.0
1925,february6,1.0
1926,march2015,1.0
1927,liable,1.0
1928,november 27,1.0
1929,correction,1.0
1930,revise,1.0
1931,january 21,1.0
1932,grounds,1.0
1933,accrue,1.0
1934,likelihood,1.0
1935,december,1.0
1936,addition,1.0
1937,assigned,1.0
1938,possession,1.0
1939,patent,1.0
1940,copyright,1.0
1941,trademark,1.0
1942,proprietary,1.0
1943,indemnify,1.0
1944,replace,1.0
1945,modify,1.0
1946,terminate,1.0
1947,refund,1.0
1948,aware,1.0
1949,august1,1.0
1950,offered,1.0
1951,rule144a,1.0
1952,deducting,1.0
1953,arrears,1.0
1954,mature,1.0
1955,redeemed,1.0
1956,converted,1.0
1957,indenture,1.0
1958,bank,1.0
1959,trustee,1.0
1960,may1,1.0
1961,close,1.0
1962,circumstances,1.0
1963,occurrence,1.0
1964,election,1.0
1965,remainder,1.0
1966,excess,1.0
1967,represents,1.0
1968,connection,1.0
1969,entitled,1.0
1970,form,1.0
1971,redeem,1.0
1972,asc 470,1.0
1973,accreted,1.0
1974,refer,1.0
1975,february2013,1.0
1976,began,1.0
1977,april2014,1.0
1978,asc815,1.0
1979,april17,1.0
1980,november1,1.0
1981,february2018,1.0
1982,translated,1.0
1983,january11,1.0
1984,llc,1.0
1985,affiliate,1.0
1986,books,1.0
1987,point,1.0
1988,ensure,1.0
1989,set,1.0
1990,maintained,1.0
1991,maintain,1.0
1992,generate,1.0
1993,affirmative,1.0
1994,record,1.0
1995,november27,1.0
1996,january21,1.0
1997,discussion,1.0
1998,sufficiency,1.0
1999,expectations,1.0
2000,ability,1.0
2001,mitigate,1.0
2002,meet,1.0
2003,objectives,1.0
2004,identified,1.0
2005,words,1.0
2006,predicts,1.0
2007,result,1.0
2008,partii,1.0
2009,parti,1.0
2010,filings,1.0
2011,investors,1.0
2012,manufactures,1.0
2013,aim,1.0
2014,lives,1.0
2015,image,1.0
2016,dedicated,1.0
2017,full,1.0
2018,enables,1.0
2019,treated,1.0
2020,desire,1.0
2021,discretion,1.0
2022,depends,1.0
2023,delivered,1.0
2024,localized,1.0
2025,leukemia,1.0
2026,lymphoma,1.0
2027,organ,1.0
2028,multi,1.0
2029,makes,1.0
2030,faster,1.0
2031,clinicians,1.0
2032,dependent,1.0
2033,production,1.0
2034,shipment,1.0
2035,meets,1.0
2036,regularly,1.0
2037,doctors,1.0
2038,safety,1.0
2039,efficacy,1.0
2040,ease,1.0
2041,receipt,1.0
2042,world,1.0
2043,imrt,1.0
2044,configurations,1.0
2045,360 degrees,1.0
2046,clinician,1.0
2047,combined,1.0
2048,shape,1.0
2049,capable,1.0
2050,prostate,1.0
2051,lung,1.0
2052,head,1.0
2053,widely,1.0
2054,decades,1.0
2055,capture,1.0
2056,influenced,1.0
2057,contact,1.0
2058,build,1.0
2059,renovate,1.0
2060,prepare,1.0
2061,stand,1.0
2062,distributors,1.0
2063,europe,1.0
2064,asia,1.0
2065,cover,1.0
2066,recognizable,1.0
2067,counted,1.0
2068,incorporates,1.0
2069,cleared,1.0
2070,shipped,1.0
2071,assured,1.0
2072,site,1.0
2073,passed,1.0
2074,cancelled,1.0
2075,limitation,1.0
2076,remove,1.0
2077,adapt,1.0
2078,accommodate,1.0
2079,operation,1.0
2080,dollars,1.0
2081,strengthening,1.0
2082,sum,1.0
2083,revisions,1.0
2084,line,1.0
2085,introduction,1.0
2086,increases,1.0
2087,difficult,1.0
2088,forecast,1.0
2089,minimize,1.0
2090,timing,1.0
2091,enter,1.0
2092,reduce,1.0
2093,level,1.0
2094,expressed,1.0
2095,don,1.0
2096,percentages,1.0
2097,53%,1.0
2098,started,1.0
2099,materials,1.0
2100,deal,1.0
2101,lastly,1.0
2102,reductions,1.0
2103,offs,1.0
2104,strengthen,1.0
2105,comparison,1.0
2106,euro,1.0
2107,unavailable,1.0
2108,dividends,1.0
2109,anticipate,1.0
2110,repatriate,1.0
2111,summarized,1.0
2112,accretion,1.0
2113,releases,1.0
2114,collected,1.0
2115,invoicing,1.0
2116,utilized,1.0
2117,prepaids,1.0
2118,release,1.0
2119,prepayments,1.0
2120,half,1.0
2121,footnotes 5,1.0
2122,progress,1.0
2123,obtaining,1.0
2124,12months,1.0
2125,insufficient,1.0
2126,satisfy,1.0
2127,seek,1.0
2128,raised,1.0
2129,restrict,1.0
2130,reclassified,1.0
2131,topic,1.0
2132,aspects,1.0
2133,classification,1.0
2134,statement,1.0
2135,december15,1.0
2136,february2016,1.0
2137,topic,1.0
2138,consistent,1.0
2139,depend,1.0
2140,december2015,1.0
2141,concentration,1.0
2142,totaled $7,1.0
2143,obligor,1.0
2144,augment,1.0
2145,collateral,1.0
2146,letters,1.0
2147,moody,1.0
2148,rating,1.0
2149,baa3,1.0
2150,ba1,1.0
2151,april19,1.0
2152,lawsuit,1.0
2153,stipulation,1.0
2154,february12,1.0
2155,dealt,1.0
2156,rejected,1.0
2157,requests,1.0
2158,august 2016,1.0
2159,published,1.0
2160,repayable,1.0
2161,january 11,1.0
2162,substantially,1.0
2163,repay,1.0
2164,accelerated,1.0
2165,collectively,1.0
2166,tradeshows,1.0
2167,begin,1.0
2168,august24,1.0
2169,june2016,1.0
2170,exceptions,1.0
2171,09defines,1.0
2172,09recognized,1.0
2173,clarification,1.0
2174,assess,1.0
2175,measures,1.0
2176,refinancing,1.0
2177,defaults,1.0
2178,manage,1.0
2179,exposure,1.0
2180,speculative,1.0
2181,designated,1.0
2182,intended,1.0
2183,11positions,1.0
2184,review,1.0
2185,intend,1.0
2186,insignificant,1.0
2187,plant,1.0
2188,evaluated,1.0
2189,acquisition,1.0
2190,corroboration,1.0
2191,october,1.0
2192,madison,1.0
2193,simpler,1.0
2194,scale,1.0
2195,length,1.0
2196,completion,1.0
2197,pre,1.0
2198,november2016,1.0
2199,topic,1.0
2200,address,1.0
2201,clarifies,1.0
2202,august2015,1.0
2203,represented,1.0
2204,december2025,1.0
2205,october2016,1.0
2206,territories,1.0
2207,contained,1.0
2208,stated,1.0
2209,decline,1.0
2210,reduced,1.0
2211,negotiated,1.0
2212,november,1.0
2213,march2017,1.0
2214,march 31,1.0
2215,march 2017,1.0
2216,borrowings,1.0
2217,level,1.0
2218,function,1.0
